{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:07:12Z","timestamp":1762866432833,"version":"3.40.5"},"reference-count":28,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","scienceandjusticejournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Science & Justice"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.scijus.2014.06.004","type":"journal-article","created":{"date-parts":[[2014,7,2]],"date-time":"2014-07-02T09:47:02Z","timestamp":1404294422000},"page":"351-355","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Parallel artificial membrane permeability assay for blood\u2013brain permeability determination of illicit drugs and synthetic analogues"],"prefix":"10.1016","volume":"54","author":[{"given":"Kristina","family":"Clemons","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9436-2509","authenticated-orcid":false,"given":"Amanda","family":"Kretsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guido","family":"Verbeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.scijus.2014.06.004_bb0005","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1021\/jm970530e","article-title":"Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes","volume":"41","author":"Kansy","year":"1998","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.scijus.2014.06.004_bb0010","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/jps.22796","article-title":"Optimization of a parallel artificial membrane permeability assay for the fast and simultaneous prediction of human intestinal absorption and plasma protein binding of drug candidates: application to dibenz[b,f]azepine-5-carboxamide derivatives","volume":"101","author":"Fortuna","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.scijus.2014.06.004_bb0015","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ddtec.2004.11.013","article-title":"Advances in screening for membrane permeability: high-resolution PAMPA for medicinal chemists","volume":"1","author":"Kansy","year":"2004","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.scijus.2014.06.004_bb0020","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejps.2004.02.003","article-title":"PAMPA\u2014a drug absorption in vitro model 8. Apparent filter porosity and the unstirred water layer","volume":"22","author":"Nielsen","year":"2004","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.scijus.2014.06.004_bb0025","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ejps.2003.08.006","article-title":"PAMPA\u2014a drug absorption in vitro model","volume":"20","author":"Ruell","year":"2003","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.scijus.2014.06.004_bb0030","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.ejps.2012.01.011","article-title":"Skin-PAMPA: a new method for fast prediction of skin penetration","volume":"45","author":"Sinko","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.scijus.2014.06.004_bb0035","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1002\/jps.23171","article-title":"Application of membrane permeability evaluated in in vitro analyses to estimate blood-retinal barrier permeability","volume":"101","author":"Kubo","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.scijus.2014.06.004_bb0040","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0223-5234(03)00012-6","article-title":"High throughput artificial membrane permeability assay for blood\u2013brain barrier","volume":"38","author":"Di","year":"2003","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.scijus.2014.06.004_bb0045","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1021\/jm201105a","article-title":"Alpha-aryl-N-alkyl nitrones, as potential agents for stroke treatment: synthesis, theoretical calculations, antioxidant, anti-inflammatory, neuroprotective, and brain\u2013blood barrier permeability properties","volume":"55","author":"Chioua","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.scijus.2014.06.004_bb0050","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.ejpb.2010.01.003","article-title":"Evaluation of various PAMPA models to identify the most discriminating method for the prediction of BBB permeability","volume":"74","author":"Mensch","year":"2010","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.scijus.2014.06.004_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/jbb.S14-009","article-title":"Optimization and validation of an in vitro blood brain barrier permeability assay using artificial lipid membrane","volume":"S14","author":"Jhala","year":"2012","journal-title":"J. Bioequiv. Availab."},{"key":"10.1016\/j.scijus.2014.06.004_bb0060","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ijpharm.2007.05.057","article-title":"Evaluation of in vitro brain penetration: optimized PAMPA and MDCKII\u2013MDR1 assay comparison","volume":"345","author":"Carrara","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.scijus.2014.06.004_bb0065","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1002\/jps.21580","article-title":"Comparison of blood\u2013brain barrier permeability assays: in situ brain perfusion, MDR1\u2013MDCKII and PAMPA\u2013BBB","volume":"98","author":"Di","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.scijus.2014.06.004_bb0070","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ejps.2004.11.011","article-title":"Caco-2 permeability of weakly basic drugs predicted with the double-sink PAMPA pKa(flux) method","volume":"24","author":"Avdeef","year":"2005","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.scijus.2014.06.004_bb0075","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijpharm.2009.07.008","article-title":"Proliposomes of exemestane for improved oral delivery: formulation and in vitro evaluation using PAMPA, Caco-2 and rat intestine","volume":"380","author":"Hiremath","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.scijus.2014.06.004_bb0080","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0223-5234(02)01360-0","article-title":"A comparative study of artificial membrane permeability assay for high throughput profiling of drug absorption potential","volume":"37","author":"Zhu","year":"2002","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.scijus.2014.06.004_bb0085","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ddtec.2004.11.014","article-title":"Prediction of blood\u2013brain barrier permeation in drug discovery from in vivo, in vitro and in silico models","volume":"1","author":"Abbott","year":"2004","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.scijus.2014.06.004_bb0090","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1023\/B:PHAM.0000003380.44755.5a","article-title":"In Vitro permeability of poorly aqueous soluble compounds using different solubilizers in the PAMPA assay with liquid chromatography\/mass spectrometry detection","volume":"20","author":"Liu","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.scijus.2014.06.004_bb0095","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jchromb.2006.10.031","article-title":"Novel generic UPLC\/MS\/MS method for high throughput analysis applied to permeability assessment in early drug discovery","volume":"847","author":"Mensch","year":"2007","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.scijus.2014.06.004_bb0100","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jpba.2005.03.043","article-title":"A novel high-throughput automated chip-based nanoelectrospray tandem mass spectrometric method for PAMPA sample analysis","volume":"39","author":"Balimane","year":"2005","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.scijus.2014.06.004_bb0105","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1021\/np300882f","article-title":"Applicability of a blood\u2013brain barrier specific artificial membrane permeability assay at the early stage of natural product-based CNS drug discovery","volume":"76","author":"Konczol","year":"2013","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.scijus.2014.06.004_bb0110","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0378-5173(01)00845-6","article-title":"Optimized conditions of bio-mimetic artificial membrane permeation assay","volume":"228","author":"Sugano","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.scijus.2014.06.004_bb0115","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/rcm.1790","article-title":"Stable isotopically labeled internal standards in quantitative bioanalysis using liquid chromatography\/mass spectrometry: necessity or not?","volume":"19","author":"Stokvis","year":"2005","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.scijus.2014.06.004_bb0120","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/ejoc.200600937","article-title":"Aqueous-mediated N-alkylation of amines","volume":"2007","author":"Singh","year":"2007","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/j.scijus.2014.06.004_bb0125","series-title":"Pharmacokinetics and pharmacodynamics of abused drugs","first-page":"1","article-title":"Pharmacokinetics: basic concepts and models","author":"Jenkins","year":"2008"},{"key":"10.1016\/j.scijus.2014.06.004_bb0130","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1021\/jm990325u","article-title":"Further studies on oxygenated tryptamines with LSD-like activity incorporating a chiral pyrrolidine moiety into the side chain","volume":"42","author":"Gerasimov","year":"1999","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.scijus.2014.06.004_bb0135","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/cmdc.200800133","article-title":"Structure\u2013activity relationships of phenylalkylamines as agonist ligands for 5-HT(2A) receptors","volume":"3","author":"Blaazer","year":"2008","journal-title":"ChemMedChem"},{"key":"10.1016\/j.scijus.2014.06.004_bb0140","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1021\/jm00177a017","article-title":"Serotonin receptor affinities of psychoactive phenalkylamine analogues","volume":"23","author":"Glennon","year":"1980","journal-title":"J. Med. Chem."}],"container-title":["Science & Justice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1355030614000860?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1355030614000860?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T19:51:26Z","timestamp":1538423486000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1355030614000860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S1355030614000860"],"URL":"https:\/\/doi.org\/10.1016\/j.scijus.2014.06.004","relation":{},"ISSN":["1355-0306"],"issn-type":[{"type":"print","value":"1355-0306"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Parallel artificial membrane permeability assay for blood\u2013brain permeability determination of illicit drugs and synthetic analogues","name":"articletitle","label":"Article Title"},{"value":"Science & Justice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.scijus.2014.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Forensic Science Society. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}